Live, in person

24 - 27 January 2022

Dubai World Trade Centre


5 January - 28 February 2022

Telling the complete story of how big genomic data is transforming medicine



Monday, 24th January, 11:00 - 12:00
Johannesburg room, Za'abeel hall 2, Z2.A40


There are a number of advantages to genomic testing that are not limited to the establishment of a diagnosis in a single case. The use of genomic testing and data collection can have an impact on a single case, an extended family, and the healthcare system as a whole. Furthermore, genomic testing is not restricted to only rare diseases or only geneticists. In order to maximize the clinical application and clinical utility of single genomic testing, it is necessary to maximize the utilization of all benefits from genomic testing. This would be beneficial to both patients and physicians across a wide range of specialties and disciplines. In this presentation, we will describe our efforts to maximize the application of single genomic testing to clinical diagnostic and research studies while also considering the implications of these efforts for the health-care system as a whole, as well as the implications of these efforts for patients. So we were able to turn genomic data into a useful resource for the healthcare system, and this test serves as an example of a single test that can provide multiple benefits to a patient, their families, the healthcare system as a whole, and the entire society.

Learning objectives

  • Understand the implications of big genomic data for critical cases, semi-urgent patients, and cold cases
  • Demonstrate the value of genomic big data as a valuable resource for the healthcare industry
  • Acknowledge the most up-to-date medical care for all patients who have been tested
  • Genetic testing should be performed for all specialists, not just geneticists


Dr. Ahmed Alfares,
MD. Consultantin Medical Genetics at National Guard Hospital and Vice President of Saudi Society of Medical Genetics, KSA


Dr. Alfares completed medical school in Saudi Arabia and joined the medical genetics residency program at McGill University, Canada. Subsequently, he joined Harvard Medical School in 2011 and completed two fellowships training in Clinical Molecular Genetics and Clinical Biochemical Genetics. Dr. Alfares is currently working as an assistance professor at Qassim University, Saudi Arabia and as a consultant in medical genetics at National Guard Hospital. He is working on implementing high-throughput molecular genetics sequencing lab mainly for whole exome and genome within NGHA campuses also he is working as a consultant in the biochemical metabolic laboratory. 

Important note: All workshops will be on a first come, first served basis.